SCHEDULE 13G Filed 2026-06-09 Event — SEC 0000919574-26-003921 →

Point72 Asset Management, L.P. → Design Therapeutics, Inc. DSGN

Stake: — Shares: — Class: Common Stock, par value $0.0001 per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 25/100

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager
Elevated short days-to-cover (12.0 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

8 filings by this filer

7 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 11.99

6,653,634 shares short · +0.6% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $50.39M

Point72 Asset Mgmt

Other Filings by Point72 Asset Management, L.P.

Filed	Form	Issuer	Stake	Shares
2026-10-05	SCHEDULE 13G	E.W. SCRIPPS Co	—	—	view →
2026-07-08	SCHEDULE 13G	Perceptive Capital Solutions Corp	—	—	view →
2026-06-25	SCHEDULE 13G	BlockchAIn Digital Infrastructure, Inc. AIB	—	—	view →
2026-05-26	SCHEDULE 13G	Avalo Therapeutics, Inc. AVTX	—	—	view →
2026-05-22	SCHEDULE 13G	POWER SOLUTIONS INTERNATIONAL, INC. PSIX	—	—	view →
2018-04-25	SC	LAUREATE EDUCATION, INC. LAUR	—	—	view →
2018-01-05	SC	LAUREATE EDUCATION, INC. LAUR	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →